APOPTOSIS IN SKELETAL MUSCLE FOLLOWING BURN INJURY

烧伤后骨骼肌细胞凋亡

基本信息

  • 批准号:
    6520273
  • 负责人:
  • 金额:
    $ 33.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-03-01 至 2004-02-29
  • 项目状态:
    已结题

项目摘要

Burn injury, with and without sepsis, is associated with many functional and metabolic aberrations. In skeletal muscle, the important functional change is muscle weakness resulting in hypoventilation, dependence on respirators, and decreased mobilization. The neuromuscular dysfunction and muscle weakness associated with burns prolongs hospital stay, increases cost, morbidity and mortality. The long-term goals of these studies are, therefore, to characterize the etiology of muscle weakness and design strategies to improve tension-generating capacity of muscle in humans. Based on convincing preliminary data, the hypotheses tested in the present proposal is that apoptosis or programmed cell death occurs in skeletal muscle, at sites distant and immediately local to burn, with activation of pro-apoptotic signaling pathways. The goals of the present studies, using rats, are to: (1) Confirm and study the evolution of apoptosis in skeletal muscle at local and distant sites from burn, and in different fiber types (slow vs. fast twitch muscles). (2) Characterize the putative signaling pathways leading to apoptosis, previously documented only in in vitro systems. (3) Effectively inhibit some of the activated pro-apoptotic pathways and decrease muscle wasting and muscle weakness. Apoptosis will be confirmed by three independent methods- the ladder, TUNEL and ELISA assays. The cell membrane and downstream signaling molecules modulating apoptosis (e.g., TNFalpha, Fas, FasL, phosphatidylinositol 3-kinase, ceramide, BCL-2, BCL-X and caspases) will be assessed for expression and/or activity by using molecular pharmacological or biochemical techniques. The importance of certain signaling molecules will be confirmed by the use of knock out or transgenic (TNF, lpr or Fas, ceramide, BC12, and caspase) mice. Specific exogenous modulators (e.g., IGF-1 and caspase inhibitors) of some of the apoptotic signaling molecules will be used in vivo to attenuate muscle wasting due to apoptosis. These "reversal of apoptosis" studies will be performed in conjunction with protein turnover and functional studies to test the efficacy of these drugs to reverse the neuromuscular dysfunction of burns. The proposed studies will, therefore, delineate the neuromuscular dysfunction associated with burns, the component contributed to by apoptosis, and the potential for attenuation of both the apoptosis and the neuromuscular dysfunction by pharmacotherapy. Information obtained from the rat studies will provide a scientific basis and rationale for therapeutic maneuvers to prevent and/or rectify neuromuscular complications of burns or critical illness in humans.
烧伤,有或没有脓毒症,与许多功能和代谢异常。 在骨骼肌中,重要的功能变化是肌肉无力,导致通气不足、对呼吸机的依赖和活动减少。 与烧伤相关的神经肌肉功能障碍和肌无力延长了住院时间,增加了费用、发病率和死亡率。 因此,这些研究的长期目标是描述肌无力的病因学,并设计策略来改善人类肌肉的张力产生能力。基于令人信服的初步数据,在本提案中测试的假设是,细胞凋亡或程序性细胞死亡发生在骨骼肌中,在远离和立即本地烧伤的部位,与促凋亡信号通路的激活。本研究的目的是:(1)确认和研究烧伤后局部和远处骨骼肌以及不同纤维类型(慢肌和快肌)中细胞凋亡的演变。 (2)表征导致细胞凋亡的假定信号通路,以前仅在体外系统中记录。 (3)有效抑制一些激活的促凋亡途径,减少肌肉萎缩和肌肉无力。细胞凋亡将通过三种独立的方法证实-梯状、TUNEL和ELISA测定。 调节细胞凋亡的细胞膜和下游信号分子(例如,TNF α、Fas、FasL、磷脂酰肌醇3-激酶、神经酰胺、BCL-2、BCL-X和半胱天冬酶)的表达和/或活性。 某些信号分子的重要性将通过使用敲除或转基因(TNF、lpr或Fas、神经酰胺、BC 12和胱天蛋白酶)小鼠来证实。 特异性外源调节剂(例如,IGF-1和半胱天冬酶抑制剂)将在体内用于减弱由于细胞凋亡引起的肌肉萎缩。 这些“细胞凋亡逆转”研究将与蛋白质周转和功能研究一起进行,以测试这些药物逆转烧伤神经肌肉功能障碍的疗效。因此,拟议的研究将描述与烧伤相关的神经肌肉功能障碍,细胞凋亡的组成部分,以及通过药物治疗减轻细胞凋亡和神经肌肉功能障碍的潜力。从大鼠研究中获得的信息将为预防和/或纠正人类烧伤或危重疾病的神经肌肉并发症的治疗策略提供科学依据和原理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jeevendra Martyn其他文献

Jeevendra Martyn的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jeevendra Martyn', 18)}}的其他基金

Major Burn Injury and its Effects on Acute and Superimposed Surgical Pain
严重烧伤及其对急性和叠加手术疼痛的影响
  • 批准号:
    10033365
  • 财政年份:
    2020
  • 资助金额:
    $ 33.72万
  • 项目类别:
Major Burn Injury and its Effects on Acute and Superimposed Surgical Pain
严重烧伤及其对急性和叠加手术疼痛的影响
  • 批准号:
    10465102
  • 财政年份:
    2020
  • 资助金额:
    $ 33.72万
  • 项目类别:
Major Burn Injury and its Effects on Acute and Superimposed Surgical Pain
严重烧伤及其对急性和叠加手术疼痛的影响
  • 批准号:
    10684657
  • 财政年份:
    2020
  • 资助金额:
    $ 33.72万
  • 项目类别:
Major Burn Injury and its Effects on Acute and Superimposed Surgical Pain
严重烧伤及其对急性和叠加手术疼痛的影响
  • 批准号:
    10237933
  • 财政年份:
    2020
  • 资助金额:
    $ 33.72万
  • 项目类别:
Synaptic and Nerve Terminal Changes and Associated Muscle Weakness of Burn Injury
突触和神经末梢变化以及烧伤相关的肌肉无力
  • 批准号:
    9247895
  • 财政年份:
    2016
  • 资助金额:
    $ 33.72万
  • 项目类别:
APOPTOSIS IN SKELETAL MUSCLE FOLLOWING BURN INJURY
烧伤后骨骼肌细胞凋亡
  • 批准号:
    6636472
  • 财政年份:
    2000
  • 资助金额:
    $ 33.72万
  • 项目类别:
APOPTOSIS IN SKELETAL MUSCLE FOLLOWING BURN INJURY
烧伤后骨骼肌细胞凋亡
  • 批准号:
    6363354
  • 财政年份:
    2000
  • 资助金额:
    $ 33.72万
  • 项目类别:
APOPTOSIS IN SKELETAL MUSCLE FOLLOWING BURN INJURY
烧伤后骨骼肌细胞凋亡
  • 批准号:
    6135371
  • 财政年份:
    2000
  • 资助金额:
    $ 33.72万
  • 项目类别:
Molecular Pharmacology of Insulin Resistance in Burns
烧伤胰岛素抵抗的分子药理学
  • 批准号:
    6729136
  • 财政年份:
    1997
  • 资助金额:
    $ 33.72万
  • 项目类别:
Molecular Pharmacology of Insulin Resistance in Burns
烧伤胰岛素抵抗的分子药理学
  • 批准号:
    7585601
  • 财政年份:
    1997
  • 资助金额:
    $ 33.72万
  • 项目类别:

相似海外基金

NOVEL RNASE PROTECTION ASSAY FOR CYTOKINE MRNAS
细胞因子 MRNAS 的新型 RNA 酶保护测定
  • 批准号:
    6317727
  • 财政年份:
    2000
  • 资助金额:
    $ 33.72万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了